CClinicalTrials.gg
CompletedNCT01131143IVRUpdated Apr 2, 2013

Trial of Provider-to-Patient Interactive Voice Response (IVR) Calls to Improve Weight Management in Community Health Centers (CHCs)

An interventional study of Provider Voice and Generic Voice in Obesity, sponsored by Indiana University. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-04-02.

Sponsored by Indiana University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
1,228
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study will test the effect of provider to patient interactive voice response (IVR) calls in local Community Health Centers within a weight management program.

Read the detailed description

We will randomize providers to three groups. Patients whose provider has been randomized to usual care will not receive IVR calls but do have available a guideline-level weight management service in TCL. Groups one and two will receive pre-visit and post-referral calls. The pre-visit call will invite patients who want to discuss weight at their upcoming visit with their provider to remember to do so. The post-referral call will remind patients that they have received a referral and encourage them to schedule a visit with the community based weight intervention program. Patients whose provider has been randomized to group 1 will receive IVR calls using their scheduled and referring provider's voice. Group 2 will receive IVR calls using a standard IVR voice.

02

Conditions studied

  • Obesity

Browse trials for

Keywords

  • Urban community centers
  • Obesity
  • Obesity counseling
  • Low-cost intervention
03

In context

Obesity

6,296 studies on the registry are indexed under Obesity; 1,692 are open to participants now.

This study's enrollment of 1,228 is above the median of 78 across 4,878 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Indiana University is the lead sponsor of 958 studies on the registry; 200 are open to participants now.

Of its 142 completed or terminated interventional studies of FDA-regulated products, 112 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Adult patients who have screened positive for overweight or obesity

Exclusion criteria

Exclusion Criteria:

  • Patients who have not screened positive for overweight or obesity
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
1,228 participants (actual)

Study arms

  • Experimental
    Treatment Group 1

    Patients will receive a pre-visit, post-referral and post-contact phone call using providers voice

    Behavioral: Provider Voice

  • Experimental
    Treatment Group 2

    Patients will receive a previsit, post-referral and post-contact call using a generic voice

    Behavioral: Generic Voice

  • No intervention
    Treatment Group 3

    Patients will be provided usual care with no additional phone calls.

Interventions

  • BehavioralProvider Voice

    A phone call with the pre-recorded doctor's voice will be made to their patients who have been pre-screened for obesity before the patient's appointments prompting the patients to ask about physical activity, nutrition, and weight loss.

  • BehavioralGeneric Voice

    A phone call with a pre-recorded neutral voice will be made to the doctor's patients who have been prescreened for obesity before their patient's appointments. The call will prompt them to ask ask their doctor about physical activity, nutrition, and weight loss.

06

What researchers measure

Primary outcomes

  1. Weight loss refer by provider

    Time frame: 6 months

Secondary outcomes

  1. attendance at program, weight loss

    Time frame: 6 months

07

Study locations

1 site
  • Indiana University Center on Aging Research-Regenstrief Institute
    Indianapolis, Indiana 46202, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 2, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01131143
Lead sponsor
Indiana University
Responsible party
Kimberly Hemmerlein (Researcher Coodinator, Indiana University) — Principal investigator
First posted
May 26, 2010
Start date
Jun 2009
Primary completion
Dec 2010
Completion
Jan 2012
Last update
Apr 2, 2013

Study contacts

Daniel O Clark, PhD
principal investigator · Indiana School of Medicine

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion